172 related articles for article (PubMed ID: 28615069)
1. Regulatory landscape fusion in rhabdomyosarcoma through interactions between the PAX3 promoter and FOXO1 regulatory elements.
Vicente-García C; Villarejo-Balcells B; Irastorza-Azcárate I; Naranjo S; Acemel RD; Tena JJ; Rigby PWJ; Devos DP; Gómez-Skarmeta JL; Carvajal JJ
Genome Biol; 2017 Jun; 18(1):106. PubMed ID: 28615069
[TBL] [Abstract][Full Text] [Related]
2. Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity.
Nakazawa K; Shaw T; Song YK; Kouassi-Brou M; Molotkova A; Tiwari PB; Chou HC; Wen X; Wei JS; Deniz E; Toretsky JA; Keller C; Barr FG; Khan J; Üren A
Cancer Res Commun; 2023 Oct; 3(10):2030-2043. PubMed ID: 37732905
[TBL] [Abstract][Full Text] [Related]
3. PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors.
Searcy MB; Larsen RK; Stevens BT; Zhang Y; Jin H; Drummond CJ; Langdon CG; Gadek KE; Vuong K; Reed KB; Garcia MR; Xu B; Kimbrough DW; Adkins GE; Djekidel N; Porter SN; Schreiner PA; Pruett-Miller SM; Abraham BJ; Rehg JE; Hatley ME
Nat Commun; 2023 Nov; 14(1):7291. PubMed ID: 37968277
[TBL] [Abstract][Full Text] [Related]
4. PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and RNA polymerase pause release at select gene targets.
Zhang S; Wang J; Liu Q; McDonald WH; Bomber ML; Layden HM; Ellis J; Borinstein SC; Hiebert SW; Stengel KR
Mol Cell; 2022 Dec; 82(23):4428-4442.e7. PubMed ID: 36395771
[TBL] [Abstract][Full Text] [Related]
5. PAX3-FOXO1 uses its activation domain to recruit CBP/P300 and shape RNA Pol2 cluster distribution.
Asante Y; Benischke K; Osman I; Ngo QA; Wurth J; Laubscher D; Kim H; Udhayakumar B; Khan MIH; Chin DH; Porch J; Chakraborty M; Sallari R; Delattre O; Zaidi S; Morice S; Surdez D; Danielli SG; Schäfer BW; Gryder BE; Wachtel M
Nat Commun; 2023 Dec; 14(1):8361. PubMed ID: 38102136
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas9-Mediated Bioluminescent Tagging of Endogenous Proteins by Fluorescent Protein-Assisted Cell Sorting.
Hawley RG; Hawley TS
Methods Mol Biol; 2024; 2779():273-286. PubMed ID: 38526790
[TBL] [Abstract][Full Text] [Related]
7. Invariant TAD Boundaries Constrain Cell-Type-Specific Looping Interactions between Promoters and Distal Elements around the CFTR Locus.
Smith EM; Lajoie BR; Jain G; Dekker J
Am J Hum Genet; 2016 Jan; 98(1):185-201. PubMed ID: 26748519
[TBL] [Abstract][Full Text] [Related]
8. Rhabdomyosarcomas are oncogene addicted to the activation of AVIL.
Xie Z; Janczyk PL; Shi X; Wang Q; Singh S; Cornelison R; Xu J; Mandell JW; Barr FG; Li H
Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2118048119. PubMed ID: 37146302
[TBL] [Abstract][Full Text] [Related]
9. Mutant myogenin promoter-controlled oncolytic adenovirus selectively kills PAX3-FOXO1-positive rhabdomyosarcoma cells.
Yoshida H; Sato-Dahlman M; Hajeri P; Jacobsen K; Koodie L; Yanagiba C; Shanley R; Yamamoto M
Transl Oncol; 2021 Feb; 14(2):100997. PubMed ID: 33338875
[TBL] [Abstract][Full Text] [Related]
10. NFκB signaling in alveolar rhabdomyosarcoma.
Cleary MM; Mansoor A; Settelmeyer T; Ijiri Y; Ladner KJ; Svalina MN; Rubin BP; Guttridge DC; Keller C
Dis Model Mech; 2017 Sep; 10(9):1109-1115. PubMed ID: 28883017
[TBL] [Abstract][Full Text] [Related]
11. Impact of genome architecture on the functional activation and repression of Hox regulatory landscapes.
Rodríguez-Carballo E; Lopez-Delisle L; Yakushiji-Kaminatsui N; Ullate-Agote A; Duboule D
BMC Biol; 2019 Jul; 17(1):55. PubMed ID: 31299961
[TBL] [Abstract][Full Text] [Related]
12. Co-localization of clusters of TCR-regulated genes with TAD rearrangements.
Gao GF; Li P; Leonard WJ
BMC Genomics; 2023 Oct; 24(1):650. PubMed ID: 37898735
[TBL] [Abstract][Full Text] [Related]
13. Structural Fluctuations of the Chromatin Fiber within Topologically Associating Domains.
Tiana G; Amitai A; Pollex T; Piolot T; Holcman D; Heard E; Giorgetti L
Biophys J; 2016 Mar; 110(6):1234-45. PubMed ID: 27028634
[TBL] [Abstract][Full Text] [Related]
14. TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma.
Gallo-Oller G; Pons G; Sansa-Girona J; Navarro N; Zarzosa P; García-Gilabert L; Cabré-Fernandez P; Guillén Burrieza G; Valero-Arrese L; Segura MF; Lizcano JM; Sánchez de Toledo J; Moreno L; Gallego S; Roma J
Exp Hematol Oncol; 2024 Apr; 13(1):38. PubMed ID: 38581035
[TBL] [Abstract][Full Text] [Related]
15. Cellular reprogramming is driven by widespread rewiring of promoter-enhancer interactions.
Wang M; He B; Hao Y; Srinivasan D; Shrinet J; Fraser P
BMC Biol; 2023 Nov; 21(1):264. PubMed ID: 37981682
[TBL] [Abstract][Full Text] [Related]
16. How subtle changes in 3D structure can create large changes in transcription.
Xiao JY; Hafner A; Boettiger AN
Elife; 2021 Jul; 10():. PubMed ID: 34240703
[TBL] [Abstract][Full Text] [Related]
17. Topologically associating domains define the impact of de novo promoter variants on autism spectrum disorder risk.
Nakamura T; Ueda J; Mizuno S; Honda K; Kazuno AA; Yamamoto H; Hara T; Takata A
Cell Genom; 2024 Feb; 4(2):100488. PubMed ID: 38280381
[TBL] [Abstract][Full Text] [Related]
18. Enhancer-promoter interactions can form independently of genomic distance and be functional across TAD boundaries.
Balasubramanian D; Borges Pinto P; Grasso A; Vincent S; Tarayre H; Lajoignie D; Ghavi-Helm Y
Nucleic Acids Res; 2024 Feb; 52(4):1702-1719. PubMed ID: 38084924
[TBL] [Abstract][Full Text] [Related]
19. Mutant FOXO1 controls an oncogenic network via enhancer accessibility.
Layden HM; Ellis JD; Bomber ML; Bartlett LN; Hiebert SW; Stengel KR
Cell Genom; 2024 Apr; 4(4):100537. PubMed ID: 38604128
[TBL] [Abstract][Full Text] [Related]
20. Boundary stacking interactions enable cross-TAD enhancer-promoter communication during limb development.
Hung TC; Kingsley DM; Boettiger AN
Nat Genet; 2024 Feb; 56(2):306-314. PubMed ID: 38238628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
